Clinical Trial Update: Metabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC) [Phase 2]

View source ↗

Summary

Phase 2 metabolic balance study of apraglutide in patients with short bowel syndrome and intestinal failure (including colon-in-continuity) has completed, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Failure
• Short Bowel Syndrome

Drugs mentioned

• Apraglutide (apraglutide)

Snippet

Sponsor: VectivBio AG | Conditions: Short Bowel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2025-06-18